Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN100368388C. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100368388C details a novel Knoevenagel synthesis for cyano-substituted resveratrol analogues, offering enhanced antitumor activity and scalable production for pharmaceutical intermediates.